Jeffrey M. Tang

发表

Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.

T. Golub, P. Kantoff, M. Rubin, 2008, Journal of the National Cancer Institute.

Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States

Arul M Chinnaiyan, Martin G Sanda, Mark A Rubin, 2009, Clinical Cancer Research.

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.

Ryan D. Morin, L. Staudt, W. Wilson, 2020, Cancer cell.

Non-coding NFKBIZ 3′ UTR mutations promote cell growth and resistance to targeted therapeutics in diffuse large B-cell lymphoma

Ryan D. Morin, L. Staudt, W. Wilson, 2021, bioRxiv.

Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review

Wyeth W. Wasserman, Ron A. Wevers, Emma Graham, 2018, Journal of Inherited Metabolic Disease.

Nfkbiz 3′ UTR Mutations Confer Selective Growth Advantage and Affect Drug Response in Diffuse Large B-Cell Lymphoma

D. Scott, A. Mottok, A. Telenius, 2020 .

--The double hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH.

Ryan D. Morin, D. Scott, S. Ben-Neriah, 2019, Blood.

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.

Ryan D. Morin, R. Gascoyne, D. Scott, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Collaborative intra-tumor heterogeneity detection

Martin Ester, Salem Malikic, Sahand Khakabimamaghani, 2019, Bioinform..

PRPS-ST: A protocol-agnostic self-training method for gene expression-based classification of blood cancers.

Jeffrey Tang, Aixiang Jiang, Laura K Hilton, 2020, Blood cancer discovery.

Robust gene expression-based classification of cancers without normalization

David W. Scott, Ryan D. Morin, Bruno M. Grande, 2020, bioRxiv.

Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection.

Donna P Ankerst, Martin G Sanda, Ian M Thompson, 2009, The Journal of urology.